archive-nz.com » NZ » B » BBRAUN.CO.NZ

Total: 448

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • B. Braun Melsungen AG - Company - Quality - Product Life Cycle - Production
    Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Company Quality Product Life Cycle Production Production Once the development of a new product and its manufacturing process have been completed large scale production can begin For this B Braun uses the latest technologies and procedures Most of the machines and processes used are designed by B Braun itself so that quality and

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7804.html (2016-05-02)
    Open archived version from archive


  • B. Braun Melsungen AG - Company - Quality - Product Life Cycle - Market Supply & Logistics
    Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Company Quality Product Life Cycle Market Supply Logistics Market Supply Logistics Once a product has been manufactured it is delivered to customers High quality standards apply here too the deliveries are monitored by B Braun continuously regardless of the means of transport and carrier Packaging controls ensure the goods arrive at

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7802.html (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Company - Quality - Product Life Cycle - Services & Market Observation
    Quality Qualitiy Principles Product Life Cycle Product Concept Development Production Market Supply Logistics Services Market Observation Manufacturing Quality Sustainability History Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Company Quality Product Life Cycle Services Market Observation Services Market Observation B Braun s work does not end after delivery to the customer as training of users in the use of the products also belongs to the company s services The general intention here is to improve ourselves continuously and to share know how B Braun therefore involves itself in many different ways seeks close contact with participants from all sectors of the healthcare market and in this way tries to anticipate and drive developments B Braun aims to offer the greatest possible transparency when it comes to dealing with mistakes and complaints customers are informed promptly of the status of the investigation into their inquiry The product lifecycle ends with disposal and recycling Here too B Braun maintains high quality standards substantiated by certificates to minimize the impact on the environment and resources as

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7800.html (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Company - Quality - Manufacturing Quality - Infusion Solution
    The Infusion Solution Further Processing And Testing Of The Full Infusion Solution Container Sterilization Of The Infusion Solution Labeling And Packing Of The Infusion Solution Containers Production Steps 1 to 5 1 Production Of High Purity Water WFI Water For Injection A special sterile water so called water for injection WFI is needed to manufacture infusion solutions It is made from fully deionized drinking water which is distilled a second time The WFI is then stored at a specific temperature until it is pumped through stainless steel pipes into the production process The quality requirements of WFI are defined in national pharmaco poeia 2 Receiving Inspection Of The Raw Materials The individual raw materials for the infusion solutions e g common salt or glucose must satisfy high quality requirements They are therefore checked carefully after delivery and can only be used for production after approval by the receiving laboratory 3 Weighing Of The Raw Materials Before actual preparation of the infusion solutions can begin the raw materials needed are first weighed into doses for the order and recipe in question and then filled into containers until used 4 Preparation Of The Infusion Solution The mixing tanks are first filled to 80 percent with WFI The previously weighed raw materials are then added and dissolved in the water by stirring When the raw materials have been dissolved completely the tank is filled to 100 percent with WFI The finished infusion solution then runs through two filters which can filter particles up to a size of 0 2 micrometers out of the solution 5 Filling Of The Infusion Solution The finished infusion solution preparations are filled either into glass bottles or into Ecoflac plus containers a bag bottle made of polyethylene We would like to describe the filling process on the basis

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7815.html (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Company - Quality - Manufacturing Quality - Hip Prosthesis
    Vascular Diagnosis and Therapy Wound Closure Home Company Quality Manufacturing Quality Hip Prosthesis Hip Prosthesis New Quality of Life through High Class Prostheses To be able to move without pain a deep desire of many people suffering from hip disease The hip prostheses offered by our Aesculap Division give patients the chance for a new quality of life Together with the doctor our Aesculap Division develops a customized solution for

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7817.html (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Company - Sustainability - Sports & Health - Eurospital
    hospital football champions Eberswalde Hospital triumphed over their European counterparts Germany wins the Eurospital trophy Melsungen On September 6 Eberswalde Hospital were declared the winners of Eurospital 2008 the European football championship for hospitals outplaying teams from 14 European countries to win the coveted Eurospital trophy for 2008 In the final the 2008 German hospital football champions beat runners up Italy 5 4 after a penalty shoot out The last German hospital team to win the cup was Bayreuth Hospital in 2000 The winner from Werner Forßmann Hospital Eberswalde The Eurospital event gave Melsungen the opportunity to present itself to an international audience which it did to great effect When not working up a sweat on the football pitch the participants visited the city of Melsungen and the production facilities of tournament hosts B Braun Melsungen AG and were suitably impressed by all they saw Gerry Reid from Ireland declared it a very enjoyable occasion and an unforgettable tournament Jiri Chvojka from the Czech Republic commended the excellent organization to which many Melsungen locals had also contributed from the medical service the Melsungen referee division and municipal authorities to local football club Melsungen 08 An important contribution to the success of the event was also made by the B Braun company sports group and the many voluntary helpers and above all the country guides all of whom ensured that the stay in Melsungen was an unforgettable experience for the 350 guests from Belgium England Ireland Italy the Netherlands Austria Portugal San Marino Scotland Slovakia Slovenia Sweden and the Czech Republic I would like to thank B Braun for their support and hospitality said Eurospital President Joop Vossen from the Dutch city of Venlo on behalf of all participants On the Saturday morning the Eurospital President officially kicked off the tournament

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7512.html (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Company - Sustainability - Environmental Responsibility - Ecomanagement
    Zealand Organization Philosophy Facts Figures Work Environment Quality Sustainability Sports Health Environmental Responsibility Ecomanagement REACH regulation Environmental and Occupational Health Safety Policy Social Responsibility Compliance Code of Conduct History Product QuickFinder Continence Care Urology Diabetes Care Infection Prevention Infusion Therapy IV Drugs Neurosurgery Orthopaedics Other Products Regional Anesthesia Skin and Wound Management Spine Stoma Care Surgical Technologies Vascular Diagnosis and Therapy Wound Closure Home Company Sustainability Environmental Responsibility Ecomanagement Ecomanagement Established Standard Worldwide Injection molded parts are recycled in order to minimize waste and resource consumption A company needs to have suitable structures in place if it wants to systematically implement environmental protection in its business activities At B Braun we have introduced eco management systems to document our environmental protection efforts In 1996 our Pharma Division in Melsungen Germany was the first of our locations to be audited under the terms of Council Regulation EEC No 1836 93 allowing voluntary participation by companies in the industrial sector in a Community eco management and audit scheme environmental audit or EMAS regulation Since then we have successively expanded our eco management systems to additional production sites We are proud that four facilities of the B Braun Group in Germany Melsungen Berlin

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7516.html (2016-05-02)
    Open archived version from archive

  • B. Braun Melsungen AG - Company - Sustainability - Environmental Responsibility - REACH regulation
    Technologies Vascular Diagnosis and Therapy Wound Closure Home Company Sustainability Environmental Responsibility REACH regulation REACH regulation B Braun informed Reporting requirement according to paragraph 33 of the REACH regulation EG No 1907 2006 B Braun confirms with the CE labelling and with the declaration of conformity of our medical devices that the respective products are in compliance with the essential requirements of the European Medical Device Directive 93 42 EWG dated June 14th 1993 and the German Act on Medical Devices This includes that the below mentioned medical devices are designed and manufactured in a way that when used under the conditions and for the purpose intended they will not compromise the clinical condition or the safety of patients nor the safety and health of users or third parties if the products are used under the intended condition and purpose Respective assessments are executed e g in combination with the implementation of the risk management system according to ISO 14971 Since adoption of the European Directive REACH Registration Evaluation and Authorisation of Chemicals we have to inform which devices include a substance named in the so called list of candidates in a concentration of more than 0 1 mass percentage This list has been announced to public on the ECHA website European chemical Agency on October 28th 2008 and has been updated continuously According to substances published in the list of candidates only DEHP Bis 2 ethyl hexyl phthalate is present in relevant concentrations in some of our products medical devices The affected products from the Hospital Care Division the DEHP to more than 0 1 mass percentage mentioned are labeled as follows The identification is based on the following rules Directives 67 548 EEC 1999 45 EC and EC Regulation No 1272 2008 CLP Regulation and the REACH Regulation

    Original URL path: http://www.bbraun.co.nz/cps/rde/xchg/cw-bbraun-en-nz/hs.xsl/7518.html (2016-05-02)
    Open archived version from archive